VICTORIA, British Columbia (AP) _ Aurinia Pharmaceuticals Inc. (AUPH) on Tuesday reported a loss of $12.4 million in its first quarter.
The Victoria, British Columbia-based company said it had a loss of 14 cents per share. Losses, adjusted for non-recurring gains, were 16 cents per share.
The results matched Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was also for a loss of 16 cents per share.
The biotechnology company posted revenue of $30,000 in the period.
Aurinia shares have declined 11% since the beginning of the year. In the final minutes of trading on Tuesday, shares hit $6.06, a drop of roughly 3% in the last 12 months.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on AUPH at https://www.zacks.com/ap/AUPH